Wearable 2-week ECG to detect atrial fibrillatio
Phase 3
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-jRCTs032180018
- Lead Sponsor
- Machino Takeshi
- Brief Summary
Wearable 2-week ECG unveiled AF recurrence, which was underdiagnosed with a Holter 24-hour ECG. A 2-week monitoring period overcame the deteriorated acquisition rate of wearable ECG for unveiling the hidden AF recurrence on Holter 24-hour ECG.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 67
Inclusion Criteria
Patients who underwent an initial catheter ablation for atrial fibrillation
Exclusion Criteria
1) Allergies
2) Very sensitive skin to adhesive tape with a history of redness, erosion and scar
3) Cardiac implantable electronic devices
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method